Skip to main content
Premium Trial:

Request an Annual Quote

Research Consortium Sequences Plant Pathogen A. tumefaciens

NEW YORK, Dec. 17 — An international consortium of industry and academic scientists has sequenced the genome of Agrobacterium tumefaciens, a plant pathogen that has become a workhorse for agricultural genetic engineering.


Results of the group's research appear in the Dec. 14 issue of Science.


The genomic project, launched in late 2000, was funded by the National Science Foundation and led by researchers from the University of Washington and at DuPont, with other collaborators at The Institute for Genomic Research, SRI International, Pioneer Hi-Bred, and Brazil's University of Campinas.

Before this partnership began, DuPont had already finished a rough draft of the sequence. The company, however, agreed to make all sequence data  public if the NSF funded the last stages of the effort.


Data are hosted by the University of Washington at Menlo Park., Calif.-based SRI International contributed to the project with its Pathway Tools software, generating a computational analysis of the metabolic pathways in the bacterium. That data are available at


A. tumefaciens is a common soil bacterium that causes crown gall disease. It has become useful in agricultural biotechnology for its ability to transfer plasmid DNA into plant genomes, where it is stably integrated. Researchers also hope that by studying the bacterium they will be better able to understand the interactions between plants, animals, and the pathogens that infect them.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.